Last reviewed · How we verify

NCT04378062: PAPDAP

Pain After Proximal Digital Amputation Prevention

Terminated NA Last updated 30 August 2023
What this trial tests

NA trial testing Digital nerve procedure in Pain in 39 participants. Terminated before completion.

Timeline
1 March 2020
Primary endpoint
1 February 2023
1 February 2023

Quick facts

Lead sponsorIndiana University
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment39
Start date1 March 2020
Primary completion1 February 2023
Estimated completion1 February 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Indiana University

Who can join

18 and older, any sex, with Pain or Amputation Neuroma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Finger amputations are common and may be complicated by debilitating nerve pain. This study seeks to determine if nerve pain after digital amputation can be more effectively prevented with either of two new surgical techniques-targeted muscle reinnervation (TMR) or regenerative peripheral nerve interfaces (RPNI)-compared to standard treatment by traction neurectomy (TN).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Indiana University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04378062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing